Neoadjuvant chemo affects PSA levels post-RP, but histology is unchanged


Weekly neoadjuvant chemotherapy with docetaxel (Taxotere) achieved aPSA response in almost 80% of a small group of high-risk prostate cancerpatients enrolled in a feasibility study of single-agent therapy.

Related Videos
Samuel L. Washington III, MD, answers a question during a Zoom video interview
blurred image of a clinic hallway
Dr. Kyle A. Richards in an interview with Urology Times
Expert on OAB
Experts on OAB
Expert on OAB
3d rendered illustration - bladder cancer | Image Credit: © SciePro -
stethoscope on laptop keyboard
Related Content
© 2023 MJH Life Sciences

All rights reserved.